Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 Next >
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Tickers BMY GSK INCY
Tags General Analyst Ratings Benzinga
From Benzinga
Analyst Ratings for Incyte
Tickers INCY
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
Tickers INCY
Tags Benzinga Analyst Ratings General
From Benzinga
Incyte's Earnings Outlook
Tickers INCY
Tags INCY Benzinga Market News
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
Tickers ACCD AIR ARKQ ARKW
Tags Cathie Wood Equities Coinbase
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Tickers ABBV AGLE AI AVNS
Tags KVUE SFM SVV
From Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
Tickers INCY SNDX
Tags Market News Biotech SNDX
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
Tickers ARE ASTS CNC FRT
Tags mad money Lightning Round Penny Stocks News
From Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
Tickers INCY
Tags Market News Biotech Briefs
From Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
Tickers INCY SNDX
Tags INCY SNDX Biotech
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
Tickers ACRS AGEN AXSM BMY
Tags AGEN VKTX BMY
From Motley Fool
The bull market has left these 20 companies behind, but they are primed for growth
Tickers AAPL AMZN BLK CI
Tags GOOGL SBUX OKE
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags BLKB BZI/Ratings Benzinga
From Benzinga
Why Incyte Shares Are Falling Today
Tickers INCY
Tags General why it's moving Benzinga
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags Benzinga INCY Earnings
From Benzinga
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
Tickers CTIC INCY
Tags Market News Briefs Small Cap
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
Tickers ARGX BGNE BMRN INCY
Tags BMRN LEGN INCY
From InvestorPlace
Ominous Death Cross Forms On Incyte's Chart
Tickers INCY
Tags Market News Markets Movers
From Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
Tickers INCY
Tags Benzinga Downgrades Analyst Color
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
Tickers AMH AVB BBWI BCE
Tags XMTR LUXH HBAN
From Benzinga
Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday
Tickers BA CLNN CTLT CWK
Tags Price Target analyst forecasts INCY
From Benzinga
What 13 Analyst Ratings Have To Say About Incyte
Tickers INCY
Tags Benzinga INCY BZI/AAR
From Benzinga
Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact'
Tickers INCY
Tags Health Care Trading Ideas News
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags Benzinga MGNX General
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags HRMY ESALY Market News
From InvestorPlace
Why Shares of MacroGenics Climbed Thursday
Tickers INCY MGNX PRVB
Tags MGNX Market News PRVB
From Motley Fool
Analyst Expectations for Incyte's Future
Tickers INCY
Tags Benzinga INCY BZI/AAR
From Benzinga
Incyte Discontinues LIMBER-304 On Doubts Regarding Meeting Primary Goal, Analyst Says It Underpins Some Investor Concerns
Tickers INCY
Tags Market News Biotech Briefs
From Benzinga
Why the stock market rally can keep going, says Wall Street strategist who only recently warned of a death zone.
Tickers AAPL AMC AMZN APE
Tags TSLA WW TRKA
From MarketWatch
Incyte's Return On Capital Employed Overview
Tickers INCY
Tags BZI/ROCE Market News Earnings
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.